Validation of a multiwell γ-counter for measuring high-pressure liquid chromatography metabolite profiles

Journal of Nuclear Medicine Technology

Volumn 32, Issue 1, 2004, Pages 28-32

  Greuter, Henri N J M ^a   Van Ophemert, Patricia L B ^a   Luurtsema, Gert ^a   Franssen, Eric J F ^a   Boellaard, Ronald ^a   Lammertsma, Adriaan A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Metabolizing PET tracers; Validation; Well counter performance

Indexed keywords

CARBON 11; FLUMAZENIL; TRACER; CARBON; CESIUM;

ARTICLE; BLOOD SAMPLING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; VALIDATION PROCESS; BLOOD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; INSTRUMENTATION; SCINTILLATION COUNTING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

CARBON RADIOISOTOPES; CESIUM RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUMAZENIL; HUMANS; REPRODUCIBILITY OF RESULTS; SCINTILLATION COUNTING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2942511664     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Cunningham VJ, Lammertsma AA. Radioligand studies in brain: kinetic analysis of PET data. Med Chem Res. 1995;5:79-96.
2. 11C]flumazenil 'acid' [abstract]. Q J Nucl Med. 2001;45(suppl):S11.
3. Pike VW, Halldin C, Crouzel C, et al. Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites: current status. Nucl Med Biol. 1993;20:503-525.
4. 11C] Scherring 23390. J Labelled Compd. 1993;32:518-520.